Yantai Luye Drugs Trading

Yantai Luye Drugs Trading is the primary commercial and distribution arm of Luye Pharma Group, a major international pharmaceutical company headquartered in China. The company specializes in the marketing, sales, and logistics of a diverse range of pharmaceutical products, focusing on therapeutic areas such as oncology, central nervous system (CNS) disorders, and cardiovascular health. It manages the commercialization of high-profile products including Lipusu, a liposomal paclitaxel for various cancers, and Rykindo, a long-acting injectable for schizophrenia. Additionally, the company handles the distribution of the Seroquel franchise in China following Luye Pharma's acquisition of the brand's rights in specific territories. By leveraging an extensive distribution network and professional sales force, Yantai Luye Drugs Trading plays a pivotal role in maintaining Luye Pharma's market leadership within the Chinese healthcare sector.